The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
Feyza IzcıZeynep Türe YüceGokcen DincArzu Hanım YayEsma Eryılmaz ErenDemet BolatZeynep Burçin GönenGamze Kalın ÜnüvarOrhan YıldızBilgehan AygenPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
In a CRAB sepsis model, adding MSCs to a colistin-fosfomycin treatment may be beneficial in terms of reducing bacterial loads and preventing histopathological damage.
Keyphrases
- acinetobacter baumannii
- multidrug resistant
- drug resistant
- pseudomonas aeruginosa
- gram negative
- escherichia coli
- mesenchymal stem cells
- klebsiella pneumoniae
- intensive care unit
- acute kidney injury
- stem cells
- combination therapy
- umbilical cord
- oxidative stress
- urinary tract infection
- bone marrow
- cell therapy
- replacement therapy